+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Small-Molecule APIs Market by Type (Biological, Synthetic), Production (Contract Manufacturing, In-House Manufacturing), Application - Forecast 2024-2030- Product Image
Global Small-Molecule APIs Market by Type (Biological, Synthetic), Production (Contract Manufacturing, In-House Manufacturing), Application - Forecast 2024-2030- Product Image
Sale

Global Small-Molecule APIs Market by Type (Biological, Synthetic), Production (Contract Manufacturing, In-House Manufacturing), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5532977
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Small-Molecule APIs Market size was estimated at USD 184.32 billion in 2023, USD 197.35 billion in 2024, and is expected to grow at a CAGR of 7.26% to reach USD 301.19 billion by 2030.

Small-molecule Active Pharmaceutical Ingredients are organic compounds with a low molecular weight, typically below 900 daltons. These molecules are the active components in pharmaceuticals that are responsible for eliciting the intended therapeutic effect when administered to patients. Small-molecule APIs can easily diffuse across cell membranes because of their small size and simple structure, making them particularly effective in targeting intracellular sites. Growing chronic disease prevalence, including cancer, cardiovascular, and infectious diseases, contributes to the market growth. Accelerated drug development cycles and rising adoption of generic drugs across the globe boost the utilization of small-molecule API.

However, high costs and stringent regulatory standards associated with drug development limit the growth of the market. In addition, the health effects of exposure to active pharmaceutical ingredients create hindrances to market growth. However, strategies such as outsourcing production to cost-effective locations, developing sophisticated synthesis methods, and leveraging AI in drug discovery can be potential game-changers for an industry ripe with opportunity. Further growth opportunities exist due to the burgeoning generic drugs popularity and expanding contract manufacturing sectors.

Regional Insights

The American region is characterized by a robust pharmaceutical industry, advanced healthcare infrastructure, and a strong focus on research and development. The presence of major pharmaceutical companies, along with cutting-edge biotechnology firms, contributes to the high demand for small-molecule APIs. Stringent regulations by the U.S. Food and Drug Administration (FDA) ensure high-quality standards, making American regions an attractive location for API manufacturing. Europe stands as a key market for small-molecule APIs, with a well-established pharmaceutical sector. European countries are known for their significant contributions to pharmaceutical innovation and production.

The European Medicines Agency (EMA) plays a crucial role in regulating API quality and safety, fostering a highly regulated market environment. Additionally, Europe's strategic trade agreements and a strong emphasis on generic drugs bolster the demand for small-molecule APIs in the region. The increasing incidence of lifestyle-related diseases and government initiatives to improve healthcare systems are factors that could stimulate market growth across the Middle East and Africa. The APAC region is witnessing rapid growth in the small-molecule API market, driven by emerging economies such as China, Japan, and India. These countries are becoming global hubs for API manufacturing due to lower production costs, skilled labor, and increasing investments in healthcare infrastructure. The region's large population base and growing prevalence of chronic diseases also contribute to the rising demand for pharmaceuticals and APIs.

Market Trends by Segment

  • Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
  • Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
  • Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility

Granules India invested USD 250 million in green technology. This investment aims to establish a new facility that would produce key starting materials, intermediates, and small-molecule APIs. This strategic move emphasizes the company's commitment to sustainability and innovation in the pharmaceutical industry.

SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration

SST Corporation and Viwit Pharmaceuticals entered into a strategic collaboration to enhance the promotion of small-molecule API and CDMO services in North America. This collaboration opens up new business opportunities for both companies. It is a result of SST officially qualifying Viwit as an API/CMC supplier.

API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses

Applied Pharmaceutical Innovation (API) partnered with scientists from the University of Waterloo to develop small-molecule APIs for the treatment and prevention of coronaviruses. The team is utilizing structure-based solutions to create drugs that can effectively combat multiple variants of coronaviruses, with the aim of combating future pandemics. The research primarily focuses on targeting a key protease enzyme in the virus' replication machinery. This collaboration between API and the University of Waterloo scientists is dedicated to advancing scientific knowledge and finding innovative solutions to address the global challenge of coronaviruses.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd.

This research report offers invaluable insights into various crucial aspects of the Small-Molecule APIs Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
5.1.1.2. Rising demand for generic drugs worldwide
5.1.2. Restraints
5.1.2.1. High cost associated with small-molecule APIs
5.1.3. Opportunities
5.1.3.1. Ongoing advancements in drug discovery and development
5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
5.1.4. Challenges
5.1.4.1. Stringent regulatory requirements for drug development
5.2. Market Segmentation Analysis
5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Small-Molecule APIs Market, by Type
6.1. Introduction
6.2. Biological
6.3. Synthetic
7. Small-Molecule APIs Market, by Production
7.1. Introduction
7.2. Contract Manufacturing
7.3. In-House Manufacturing
8. Small-Molecule APIs Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.3. Diabetes
8.4. Immunological Disorders
8.5. Oncology
9. Americas Small-Molecule APIs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Small-Molecule APIs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Small-Molecule APIs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
12.3.2. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
12.3.3. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 49. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 52. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 53. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 54. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 55. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 58. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 59. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 60. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 84. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 85. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 86. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 87. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 88. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 89. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 92. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 93. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 101. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 104. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 105. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 106. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 137. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 140. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 141. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 142. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 160. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 161. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 162. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 163. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 166. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 167. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 172. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 173. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 178. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 179. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 180. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 181. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 184. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 185. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 193. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 196. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 197. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 211. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 214. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 215. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 216. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 217. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 220. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 221. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 222. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 223. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 226. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 227. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 247. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 250. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 251. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 252. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 268. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 269. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 283. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • AbbVie Inc.
  • Agilent Technologies, Inc.
  • Alacrita Holdings Limited
  • Albemarle Corporation
  • Aspen Group
  • Astrazeneca PLC
  • Aurobindo Pharma Limited
  • Bachem Holding AG
  • Bio-Rad Laboratories, Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb
  • Cambrex Corporation by Permira funds
  • Carlyle Group
  • Charles River Laboratories International, Inc.
  • Deciphera Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd,
  • Gilead Sciences, Inc
  • GlaxoSmithKline PLC
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Merck KGaA
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 197.35 Billion
Forecasted Market Value ( USD ) by 2030 $ 301.19 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Global Sterile Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug (Blood Factors, Cytokines, Immunoglobulins), Indication, Distribution - Forecast 2024-2030 - Product Image

Global Sterile Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug (Blood Factors, Cytokines, Immunoglobulins), Indication, Distribution - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Pharmaceutical Intermediates Global Market Report 2024 - Product Image

Pharmaceutical Intermediates Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Pharmaceutical API Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Image

Pharmaceutical API Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • 131 Pages
  • Global
From
Global Perspectives on Astaxanthin - Product Image

Global Perspectives on Astaxanthin

  • Book
  • 824 Pages
  • Global
Accelerated Predictive Stability (APS). Fundamentals and Pharmaceutical Industry Practices - Product Image

Accelerated Predictive Stability (APS). Fundamentals and Pharmaceutical Industry Practices

  • Book
Copyright © 2002-2024 Research and Markets. All Rights Reserved.